A new trading day began on Monday, with Inovio Pharmaceuticals Inc (NASDAQ: INO) stock price up 9.71% from the previous day of trading, before settling in for the closing price of $2.06. INO’s price has ranged from $1.30 to $2.98 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 22.92% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 43.46%. With a float of $68.42 million, this company’s outstanding shares have now reached $68.70 million.
Inovio Pharmaceuticals Inc (INO) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Inovio Pharmaceuticals Inc is 0.42%, while institutional ownership is 40.93%.
Inovio Pharmaceuticals Inc (INO) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.6 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 43.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.55% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Here are Inovio Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 862.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.58, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.52 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Let’s dig in a bit further. During the last 5-days, its volume was 1.47 million. That was better than the volume of 1.27 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 63.81%.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 55.85%, which indicates a significant decrease from 82.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.14 in the past 14 days, which was lower than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.20, while its 200-day Moving Average is $1.99. However, in the short run, Inovio Pharmaceuticals Inc’s stock first resistance to watch stands at $2.41. Second resistance stands at $2.56. The third major resistance level sits at $2.75. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $1.88. Assuming the price breaks the second support level, the third support level stands at $1.73.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
With a market capitalization of 155.27 million, the company has a total of 66,730K Shares Outstanding. Currently, annual sales are 220 K while annual income is -107,250 K. The company’s previous quarter sales were 0 K while its latest quarter income was -23,520 K.
